Flotation

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.

Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.

The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.

Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.